Literature DB >> 23553577

Confidence intervals for the selected population in randomized trials that adapt the population enrolled.

Michael Rosenblum1.   

Abstract

It is a challenge to design randomized trials when it is suspected that a treatment may benefit only certain subsets of the target population. In such situations, trial designs have been proposed that modify the population enrolled based on an interim analysis, in a preplanned manner. For example, if there is early evidence during the trial that the treatment only benefits a certain subset of the population, enrollment may then be restricted to this subset. At the end of such a trial, it is desirable to draw inferences about the selected population. We focus on constructing confidence intervals for the average treatment effect in the selected population. Confidence interval methods that fail to account for the adaptive nature of the design may fail to have the desired coverage probability. We provide a new procedure for constructing confidence intervals having at least 95% coverage probability, uniformly over a large class Q of possible data generating distributions. Our method involves computing the minimum factor c by which a standard confidence interval must be expanded in order to have, asymptotically, at least 95% coverage probability, uniformly over Q. Computing the expansion factor c is not trivial, since it is not a priori clear, for a given decision rule, for which data generating distribution leads to the worst-case coverage probability. We give an algorithm that computes c, and then prove an optimality property for the resulting confidence interval procedure.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553577      PMCID: PMC5018400          DOI: 10.1002/bimj.201200080

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  12 in total

1.  Adaptive sample size calculations in group sequential trials.

Authors:  W Lehmacher; G Wassmer
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Estimation in flexible two stage designs.

Authors:  Werner Brannath; Franz König; Peter Bauer
Journal:  Stat Med       Date:  2006-10-15       Impact factor: 2.373

3.  Testing and estimation in flexible group sequential designs with adaptive treatment selection.

Authors:  Martin Posch; Franz Koenig; Michael Branson; Werner Brannath; Cornelia Dunger-Baldauf; Peter Bauer
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

Review 4.  Adaptive seamless designs: selection and prospective testing of hypotheses.

Authors:  Christopher Jennison; Bruce W Turnbull
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

5.  Evaluating treatments when a gender by treatment interaction may exist.

Authors:  E Russek-Cohen; R M Simon
Journal:  Stat Med       Date:  1997-02-28       Impact factor: 2.373

6.  Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment.

Authors:  M Rosenblum; M J Van der Laan
Journal:  Biometrika       Date:  2011-12       Impact factor: 2.445

7.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Authors:  D J Slamon; B Leyland-Jones; S Shak; H Fuchs; V Paton; A Bajamonde; T Fleming; W Eiermann; J Wolter; M Pegram; J Baselga; L Norton
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

8.  Repeated confidence intervals for group sequential clinical trials.

Authors:  C Jennison; B W Turnbull
Journal:  Control Clin Trials       Date:  1984-03

9.  Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset.

Authors:  Sue-Jane Wang; Robert T O'Neill; H M James Hung
Journal:  Pharm Stat       Date:  2007 Jul-Sep       Impact factor: 1.894

10.  Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Authors:  Irving Kirsch; Brett J Deacon; Tania B Huedo-Medina; Alan Scoboria; Thomas J Moore; Blair T Johnson
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

View more
  1 in total

1.  Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection.

Authors:  Peter K Kimani; Susan Todd; Lindsay A Renfro; Ekkehard Glimm; Josephine N Khan; John A Kairalla; Nigel Stallard
Journal:  Stat Med       Date:  2020-05-03       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.